$LIF

COGHLAN JOHN PHILIP sold $224K of LIF (indirect holdings)

COGHLAN JOHN PHILIP sold 4,000 indirectly-held shares of Life360, Inc. (LIF) at an average of $56.07 ($56.04–$56.57, $0.22M total) across 2 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · COGHLAN JOHN PHILIP
Published Jul 6, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIF
Neutral
high confidence
Mentioned
$LIF
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFNeutralLow
01

Why it matters

The newest concrete fact is the disclosed open-market sale totaling ~$224K across two trades on 2026-07-01, filed on 2026-07-06; no new company performance or guidance information is provided.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure is unlikely to drive a fundamental repricing.

03

What to watch

The sale is indirect and pre-arranged; without additional context (e.g., total insider activity, other filings), the signal quality is limited.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-06 for a 2026-07-01 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Life360, Inc. (LIF) by a director, including trade dates, prices, and 10b5-1 status.

Company-level read

Ticker impact

$LIFNeutralHigh confidence
Context

Life360 director John Philip Coghlan sold about 4,000 shares in open-market trades under a 10b5-1 plan, totaling ~$224K.

Expected impact

Low near-term impact; any effect is likely limited to short-lived sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 insider transaction (open-market sale) explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

No clear sector read-through; this is company-specific insider selling with no new business development.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as a mild negative signal, especially if paired with other bearish disclosures.

Key entities

  • Life360, Inc.

    Subject of the Form 4 insider transaction disclosure (LIF).

  • COGHLAN JOHN PHILIP

    Director who sold shares in open-market trades under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (NASDAQ: LIF) shares fell about 18% after Q2 results despite beating analyst expectations. The company reported Q2 sales up 38% and MAUs up 16% to over 100 million, with advertising revenue quadrupling to 14% of sales. Management did not raise full-year guidance, and the stock trades around 45x free cash flow.

$LIFMedAI 8/10

Life360 (LIF) Q2 2026 Earnings Call Transcript

Life360 (LIF) reported Q2 2026 revenue of $159.0 million, up 38% year over year, driven by $115.6 million subscription revenue (+31%) and $22.0 million advertising revenue (+315%) after Nativo integration. MAU rose to 102.4 million (+16%). Adjusted EBITDA was $31.1 million (+53%). Full-year subscription guidance raised to $475-$480 million; revenue $650-$685 million.

$LIFMed

Why Life360 Stock Is Crashing Today

Life360 (NASDAQ: LIF) shares fell 25.7% Tuesday after the company reported Q2 results. Q2 revenue rose 38% to $159 million, while GAAP EPS fell to $0.06. Management kept full-year revenue and profit guidance unchanged, adjusting subscription and retail hardware targets. CFO Russell Burke said AI-native transition should drive operating leverage starting in 2027.

$LIFMed

Why Life360 Stock Is Plunging Lower This Week

Life360 (LIF) shares fell about 18% for the week after the company reported Q2 earnings. According to Life360, Q2 revenue rose 38%, MAUs grew 16% to over 100 million, and adjusted EBITDA increased 53%. The stock dropped despite beating analyst expectations because management did not raise full-year guidance.

$LIFMedAI 8/10

Life360 Q2 Results: Revenue rises 38% YoY, but stock falls 25%

Life360 Inc. (NASDAQ: LIF) shares fell about 25% to $50.20 after Q2 results beat estimates but the company kept fiscal 2026 revenue guidance at $650 million to $685 million, below the $670.24 million analyst midpoint. Q2 EPS was $0.06 vs $0.01; revenue was $158.96 million vs $156.39 million. Advertising revenue hit $22 million.